Melinda J Gooderham

99PUBLICATIONS
219CO-AUTHORS
Epidemiological modellingGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (99)

|Sep 22, 2026
Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial.

|Sep 12, 2026
Real-World Evidence of Upadacitinib in Atopic Dermatitis after Inadequate Response or Intolerance to Dupilumab: The CAN UpTIMISE Study.

|Aug 28, 2026
Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCE 1 and 2 Phase 3 Trials.

|Aug 07, 2026
Simulating real-world abrocitinib use in atopic dermatitis: results from JADE REAL.

|Jun 02, 2026
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.

|May 23, 2026
Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings.

Pageof 17

Frequent Collaborators

17 joint publications

Kim Parnell

13 joint publications

Ronald Vender

10 joint publications

Jonathan I Silverberg

10 joint publications

H Chih-Ho Hong